-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
-
Summary
-
Estrella Immunopharma, Inc. quarterly Deferred Tax Assets, Operating Loss Carryforwards history and growth rate from Q3 2021 to Q2 2024.
- Estrella Immunopharma, Inc. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending June 30, 2024 was $1.84M, a 418% increase year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Growth (%)